Image de couverture de livre

Somatic Mutation Analysis of Mucin Genes and Pathways in Idiopathic Pulmonary Fibrosis

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Seo, Mikyoung
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Integrative Analysis of Endothelial Cell Senescence‐Related Genes in Idiopathic Pulmonary Fibrosis
par: Jianqiao Chen, et autres
Publié: (2025)

Retracted: Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
par: BioMed Research International
Publié: (2024)

Regulated Cell Death in Idiopathic Pulmonary Fibrosis
par: Xiaoyue Pan, et autres
Publié: (2026)

Molecular Pathways in Idiopathic Pulmonary Fibrosis: A Review of Novel Insights for Drug Design
par: Dilay Kahvecioglu
Publié: (2025)

Decoding Dysregulation of DNA Methylation in Epigenetics of Idiopathic Pulmonary Fibrosis
par: Guorao Wu, et autres
Publié: (2026)

Cytokine Expression Profiling in Idiopathic Pulmonary Fibrosis: Insights From Integrative Proteomic Analysis
par: Chenyou Shen, et autres
Publié: (2025)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
par: Sara Gangi, et autres
Publié: (2025)

The Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis
par: Yueyuan Jin, et autres
Publié: (2025)

Role of Immune Cells in Mediating the Effect of Hypothyroidism on Idiopathic Pulmonary Fibrosis
par: Zhengling Liu, et autres
Publié: (2025)

Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis
par: Sung Il Im, et autres
Publié: (2026)

Successful Tepotinib Treatment in MET Exon 14 Skipping Mutation‐Positive Lung Adenocarcinoma With Idiopathic Pulmonary Fibrosis Through Nintedanib Combination
par: Yoshiki Kato, et autres
Publié: (2025)

The telomeric DNA damage response as a therapeutic target in Idiopathic Pulmonary Fibrosis (Feature Analysis)
par: Castellini, Arianna
Publié: (2026)

Pulmonary‐Targeted Nanoparticles Interrupt the Malignant Mechanical and Biochemical Signaling Crosstalk for Idiopathic Pulmonary Fibrosis Therapy
par: Xue‐Na Li, et autres
Publié: (2025)

Causal Link and Shared Biomarkers Between Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis
par: Xixi Pan, et autres
Publié: (2025)

Patient‐Reported Outcome Scale for Idiopathic Pulmonary Fibrosis: Development and Validation in China
par: Yang Xie, et autres
Publié: (2024)

Surgical lung biopsy for Idiopathic Pulmonary Fibrosis: Is the risk–benefit ratio changing
par: Ian N. Glaspole, et autres
Publié: (2024)

An Integrative Genotyping and Gene Expression Profiling of the Mutated Human FAM111B Gene and Fibrosis‐Associated Pathway in the POIKTMP Syndrome
par: Nadine Tambwe, et autres
Publié: (2025)

Phillygenin Inhibits PI3K‐Akt–mTOR Signalling Pathway to Prevent bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice
par: Yongjia Wei, et autres
Publié: (2025)

Cell‐Surface LAMP1 is a Senescence Marker in Aging and Idiopathic Pulmonary Fibrosis
par: Gabriel Meca‐Laguna, et autres
Publié: (2025)

Mapping of Lesion Images to Somatic Mutations
par: Mehta, Rahul
Publié: (2025)

Idiopathic Pulmonary Haemorrhage, Is It Really Idiopathic?
par: Stefanie Louey, et autres
Publié: (2025)

Concurrent Somatic Mutations of the SETBP1 and KRAS Genes in Pediatric AML: A Case Report
par: Ryo Okuse, et autres
Publié: (2026)

Comparison of Retrospective Motion Compensation Techniques for Pulmonary Dynamic Ultrashort Time to Echo MRI in Suspected Idiopathic Pulmonary Fibrosis
par: Abhilash S. Kizhakke Puliyakote, et autres
Publié: (2026)

Comparative Analysis of the Efficacy of Transcutaneous Electrical Nerve Stimulation in Somatic and Idiopathic Tinnitus Patients
par: Emre Soylemez, et autres
Publié: (2025)

Bidirectional Mendelian Randomization Study: Unraveling the Link Between Idiopathic Pulmonary Fibrosis and Cardiovascular Disease
par: Lijuan Hu, et autres
Publié: (2025)

Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients
par: Roger M. Li, et autres
Publié: (2025)

Luteolin‐Loaded Hyaluronidase Nanoparticles with Deep Tissue Penetration Capability for Idiopathic Pulmonary Fibrosis Treatment
par: Bo Pan, et autres
Publié: (2024)

Double Braking Effects of Nanomedicine on Mitochondrial Permeability Transition Pore for Treating Idiopathic Pulmonary Fibrosis
par: An Lu, et autres
Publié: (2024)

Different Levels of Autophagy Activity in Mesenchymal Stem Cells Are Involved in the Progression of Idiopathic Pulmonary Fibrosis
par: Hongxia Tao, et autres
Publié: (2024)

Targeting Inflammatory and Oxidative Pathways in Idiopathic Pulmonary Fibrosis: Synergistic Effects of Quercetin and Pirfenidone in Modulating Nrf2/ PPAR ‐γ and TLR ‐4/ NF ‐ κB Pathways
par: Hanaa Wanas, et autres
Publié: (2026)

Idiopathic Pulmonary Fibrosis Is Associated With Type 1 Diabetes: A Two‐Sample Mendelian Randomization Study
par: Leyan Chen, et autres
Publié: (2025)

Immunological Features and Potential Biomarkers of Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
par: Shuai Shao, et autres
Publié: (2025)

Exertional Desaturation and Ambulatory Oxygen Therapy Requirements in People with Idiopathic Pulmonary Fibrosis. A Retrospective Study
par: Tamara Soler
Publié: (2025)

Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
par: Kazuya Tsubouchi, et autres
Publié: (2025)

CIResDiff: A Clinically-Informed Residual Diffusion Model for Predicting Idiopathic Pulmonary Fibrosis Progression
par: Jiang, Caiwen, et autres
Publié: (2024)

Nintedanib Lacks Efficacy in a Spirometry‐Confirmed and Bleomycin‐Induced Mouse Model of Idiopathic Pulmonary Fibrosis
par: Jamal Bousamaki, et autres
Publié: (2026)

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease
par: Brent A. Luedders, et autres
Publié: (2026)

Case Study: Analyzing CFTR Mutations and SNPs in Pulmonary Fibrosis Patients with Unclear Symptoms
par: Sahar Yousaf, et autres
Publié: (2024)

Linear Subepidermal Calcified Nodule With Somatic FGFR3 Mutation
par: Italo Francesco Aromolo, et autres
Publié: (2025)

Association of Somatic TET2 Mutations With Giant Cell Arteritis
par: Michelle L. Robinette, et autres
Publié: (2024)